FSA
CVS icon

Fort Sheridan Advisors’s CVS Health CVS Stock Holding History

Fort Sheridan Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$668K Sell
6,455
-52
-0.8% -$4.64K 0.07% 156
2026
Q1 		$467K Hold
6,507
– – 0.06% 193
2025
Q4 		$516K Hold
6,507
– – 0.07% 165
2025
Q3 		$491K Buy
6,507
+3,588
+123% +$246K 0.06% 167
2025
Q2 		$201K Sell
2,919
-400
-12% -$26.2K 0.03% 244
2025
Q1 		$225K Sell
3,319
-5,130
-61% -$307K 0.03% 230
2024
Q4 		$379K Sell
8,449
-200
-2% -$11.2K 0.06% 188
2024
Q3 		$544K Sell
8,649
-1,215
-12% -$70.9K 0.08% 146
2024
Q2 		$583K Sell
9,864
-6,769
-41% -$423K 0.09% 131
2024
Q1 		$1.33M Sell
16,633
-3,790
-19% -$290K 0.25% 73
2023
Q4 		$1.61M Buy
20,423
+506
+3% +$36K 0.32% 60
2023
Q3 		$1.39M Buy
19,917
+2,570
+15% +$182K 0.32% 58
2023
Q2 		$1.2M Buy
17,347
+3,559
+26% +$253K 0.27% 67
2023
Q1 		$1.02M Buy
13,788
+2,750
+25% +$231K 0.26% 70
2022
Q4 		$1.03M Sell
11,038
-276
-2% -$26.6K 0.33% 55
2022
Q3 		$1.08M Buy
11,314
+358
+3% +$35.4K 0.36% 53
2022
Q2 		$1.01M Buy
10,956
+120
+1% +$11.7K 0.33% 54
2022
Q1 		$1.1M Sell
10,836
-626
-5% -$65.8K 0.32% 56
2021
Q4 		$1.18M Buy
11,462
+836
+8% +$77.3K 0.34% 54
2021
Q3 		$902K Buy
10,626
+38
+0.4% +$3.18K 0.3% 61
2021
Q2 		$883K Buy
10,588
+3,693
+54% +$302K 0.29% 60
2021
Q1 		$519K Buy
6,895
+75
+1% +$5.46K 0.21% 77
2020
Q4 		$466K Buy
6,820
+400
+6% +$26K 0.23% 62
2020
Q3 		$375K Sell
6,420
-69
-1% -$4.29K 0.22% 63
2020
Q2 		$422K Buy
6,489
+1,612
+33% +$102K 0.26% 55
2020
Q1 		$289K Buy
4,877
+265
+6% +$17.7K 0.21% 59
2019
Q4 		$343K Buy
4,612
+4
+0.1% +$281 0.18% 73
2019
Q3 		$291K Buy
+4,608
New +$273K 0.16% 71

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fort Sheridan Advisors's CVS Position: Q2 2026 in Review

Fort Sheridan Advisors reduced its CVS Health (CVS) stake by 0.8% in Q2 2026, selling an estimated $4.64K and leaving 6,455 shares worth $668K. The position accounts for 0.07% of the portfolio, ranked #156.

Fort Sheridan Advisors first reported a position in CVS in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.61M in Q4 2023. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Fort Sheridan Advisors held 6,455 shares of CVS Health worth $668K as of Q2 2026.
  • Fort Sheridan Advisors sold 52 CVS Health shares in Q2 2026, an estimated $4.64K.
  • CVS Health made up 0.07% of Fort Sheridan Advisors's portfolio in Q2 2026, its #156 holding.
  • Fort Sheridan Advisors first reported a position in CVS Health in Q3 2019 and has held it in 28 quarters since.
  • Fort Sheridan Advisors's CVS Health position peaked at $1.61M in Q4 2023.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fort Sheridan Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.